Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02334527
Title Phase II Trial of Palbociclib (PD-0332991) in Patients With Metastatic Urothelial Cancer (UC) After Failure of First-Line Chemotherapy
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors UNC Lineberger Comprehensive Cancer Center
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Michigan Ann Arbor Michigan 48109 United States Details
North Carolina Cancer Hospital (UNC) Chapel Hill North Carolina 27599 United States Details
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field